Skip to content
Assyro AI

Title f-27 LAWS reference

Explore the full hierarchy of this title across chapters, subchapters, and parts.

Select a part from the tree to begin

Browse chapters and parts on the left to load sections

CANADA • Title f-27 Laws • Part 2.3

Part 2.3 — Vaping products

This section clarifies that 'this Act' generally does not apply to vaping products, as defined in the Tobacco and Vaping Products Act, solely because they contain nicotine or are used with nicotine-containing substances. However, the Act *does* apply if such vaping products are manufactured, sold, or represented for therapeutic uses, such as the diagnosis, treatment, mitigation, or prevention of diseases or their symptoms in humans.

What this part covers

  • This Act does not apply to vaping products (as defined in the Tobacco and Vaping Products Act) solely due to their nicotine content.
  • This Act does not apply to vaping products (as defined in the Tobacco and Vaping Products Act) solely due to their use with nicotine-containing substances.
  • Vaping products are subject to 'this Act' if they are manufactured, sold, or represented for use in the diagnosis, treatment, mitigation, or prevention of a disease, disorder, abnormal physical state, or their symptoms, in human beings.

Sections in Part 2.3

Regulatory Context

This document sits within CANADA Laws and is most useful when linked to operational submission, quality, and inspection workflows.

CANADALaws

Related Terms

Operational Use Cases

Related Actions